LUIGI PARISI: Open Payments
NPI 1184733222 · STATEN ISLAND, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,421 in 155 payments from 24 companies in 2025. Trend: 2023 $3,819 · 2024 $3,546 · 2025 $3,421
Food & beverage: $3,421
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 32 | $791 |
| Novo Nordisk Inc | 29 | $681 |
| ABBVIE INC. | 19 | $320 |
| Bayer Healthcare Pharmaceuticals Inc. | 15 | $291 |
| Eisai Inc. | 7 | $227 |
| Lilly USA, LLC | 7 | $186 |
| GlaxoSmithKline, LLC. | 9 | $166 |
| PFIZER INC. | 5 | $107 |
| Neurocrine BioSciences, Inc. | 5 | $107 |
| Amgen Inc. | 5 | $80 |
Products named: FASENRA, Ozempic, Kerendia, VRAYLAR, FARXIGA, Leqembi, Rybelsus, Wegovy.
Industry payments across NY — which companies pay providers there.
